Direkt zum Inhalt
Merck

Quantification of bindings of organometallic ruthenium complexes to GSTπ by mass spectrometry.

Journal of inorganic biochemistry (2015-03-15)
Yu Lin, Yongdong Huang, Wei Zheng, Kui Wu, Qun Luo, Yao Zhao, Shaoxiang Xiong, Fuyi Wang
ZUSAMMENFASSUNG

Electrospray ionization mass spectrometry (ESI-MS) has been widely used to identify binding sites of metal complexes to proteins. However, the MS quantification of the metal-protein coordination remains a challenge. We have recently demonstrated by ESI-MS analysis that organometallic ruthenium complexes [(η(6)-arene)Ru(en)Cl](+) (arene=p-cymene (1), biphenyl (2) or 9,10-dihydrophenanthrene (3); en=ethylenediamine) bound to human glutathione-S-transferase π (GSTπ) at Cys15 and Cys48 within the G-site, and Cys102 and Met92 on the interface of the GSTπ dimer, showing inhibitory potency against the enzyme (J. Inorg. Biochem., 128 (2013) 77-84). Herein, we developed a mass spectrometric method to quantify the binding stoichiometry of the three complexes to GSTπ. The differences in signal intensities of the heavy-labelled peptides produced by tryptic digestion of the ruthenated GSTπ complexes and the respective light-labelled peptides in the tryptic digest of equimolar GSTπ were used to calculate the binding stoichiometry at specific residues. The results indicated that the pre-complexation of GSTπ with its substrate GSH significantly reduced the bindings of the ruthenium complexes at Met92 and Cys102, but had little impact on the bindings at Cys15 and Cys48. As the inhibitory activities of the ruthenium complexes against GSTπ are similar to those against GSTπ in complexation with GSH, these results suggest that the inhibition of the ruthenium complexes on GSTπ is attributed to the ruthenation at Cys15 and Cys48. The present work provides not only insights into the understanding on the inhibitory mechanism of ruthenium complexes GSTπ, but also a general method for quantitative characterization of metal-protein interactions.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Imidazol, ReagentPlus®, 99%
Sigma-Aldrich
L-Glutathion reduziert, suitable for cell culture, BioReagent, ≥98.0%, powder
Sigma-Aldrich
Imidazol, for molecular biology, ≥99% (titration)
Sigma-Aldrich
Imidazol-Pufferlösung, BioUltra, 1 M in H2O
Sigma-Aldrich
Imidazol, BioUltra, ≥99.5% (GC)
Sigma-Aldrich
Ruthenium auf Kohlenstoff, extent of labeling: 5 wt. % loading
Sigma-Aldrich
L-Glutathion reduziert, ≥98.0%
Sigma-Aldrich
Imidazol, ACS reagent, ≥99% (titration)
Sigma-Aldrich
Imidazol, ≥99% (titration), crystalline
Sigma-Aldrich
Ruthenium, powder
USP
Imidazol, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Imidazol, BioUltra, for molecular biology, ≥99.5% (GC)
Sigma-Aldrich
Ruthenium, powder, −200 mesh, 99.9% trace metals basis
Sigma-Aldrich
Imidazol, puriss. p.a., ≥99.5% (GC)
Sigma-Aldrich
Rutheniumschwarz
Supelco
Glutathion, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-Glutathion reduziert, BioXtra, ≥98.0%
Sigma-Aldrich
Imidazol, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99%
Ruthenium, Ruthenium, foil, 6x6mm, thickness 1.0mm, 99.9%
Ruthenium, Ruthenium, pellets, 5g, max. size 10mm, 99.9%
Ruthenium, Ruthenium, foil, 25x25mm, thickness 1.0mm, 99.9%
Supelco
Imidazol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
N-Acetoxy-d3-succinimid, 98 atom % D
Ruthenium, Ruthenium, bar, 25mm x 2mm x 2mm, 99.9%
Ruthenium, Ruthenium, bar, 50mm x 2mm x 2mm, 99.9%
Ruthenium, Ruthenium, foil, 10x10mm, thickness 1.0mm, 99.9%
Ruthenium, Ruthenium, rod, 12.7mm, diameter 12.7mm, 99.9%
Ruthenium, Ruthenium, microfoil, disks, 10mm, thinness 0.025μm, specific density 30.5μg/cm2, permanent mylar 3.5μm support, 99.9%
Imidazol, European Pharmacopoeia (EP) Reference Standard
Ruthenium, Ruthenium, microfoil, disks, 10mm, thinness 0.1μm, specific density 122μg/cm2, permanent mylar 3.5μm support, 99.9%